Manage and operate the national cancer institutes federally funded research and development center (ffrdc)/frederick national laboratory for cancer research (fnlcr)
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N91025D00001
- Awardee
-
Alliance For Advancing Biomedical Research UEI RS5CNEMAQZ83
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Task orders
- 1 $2,000,000 obligated
Award facts
- Opportunity
-
- Special Notice Announcing Re-competition of the National Cancer Institute’s (NCI) Federally Funded Research and Development Center (FFRDC) Contract Special Notice · 75N91020R00062 · Posted Sep 11, 2020
- Combined order value
- $2,000,000 Current and potential, with all options
- Last date to order 18% complete
- IDV ceiling <1% used
- $88,999,704,965.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Davis-Bacon Act FAR subpart 22.4
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The federal contract IDV award is for the management and operation of the National Cancer Institute's Federally Funded Research and Development Center (FFRDC)/Frederick National Laboratory for Cancer Research (FNLCR). The prime contractor is Alliance For Advancing Biomedical Research, a non-profit organization.
The initial task order, valued at $2,000,000, is for a transition period related to the FFRDC contract, with a period of performance through August 7, 2025. The overall IDV contract has a ceiling value of $88,999,704,965 and a period of performance through January 16, 2035. The contract was awarded by the National Cancer Institute, a civilian federal agency, and does not have a set-aside designation. The contract aims to support the NCI's ongoing research and development efforts by providing rapid response capabilities and specialized resources for the biomedical research community.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Transition task order for ffrdc contract | National Cancer Institute (NIH) | $2,000,000 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | -$295,035 | |
| Supplemental Agreement for work within scope | -$4,704,965 | |
| Other Administrative Action | $0 | |
| Original award | $5,000,000 |
Quick answers
Who was awarded contract 75N91025D00001?
75N91025D00001 was awarded to Alliance For Advancing Biomedical Research by National Cancer Institute (National Institutes of Health) on January 17, 2025.
How much is contract 75N91025D00001 worth?
Orders under 75N91025D00001 have obligated $2,000,000. 75N91025D00001's own ceiling is $88,999,704,965.
How many orders have been placed under contract 75N91025D00001?
1 order has been placed under 75N91025D00001, the latest on March 7, 2025.
Who can order from contract 75N91025D00001?
75N91025D00001 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N91025D00001 competed?
The extent of competition for 75N91025D00001 was full and open competition. The government received 2 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV